Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001
-
Shares outstanding
-
145M
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
54M
-
Shares change
-
+5.59M
-
Total reported value, excl. options
-
$208M
-
Value change
-
+$10.8M
-
Put/Call ratio
-
0.2
-
Number of buys
-
61
-
Number of sells
-
-32
-
Price
-
$3.85
Significant Holders of Annexon, Inc. - Common Stock, par value $0.001 (ANNX) as of Q1 2023
120 filings reported holding ANNX - Annexon, Inc. - Common Stock, par value $0.001 as of Q1 2023.
Annexon, Inc. - Common Stock, par value $0.001 (ANNX) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54M shares
of 145M outstanding shares and own 37.19% of the company stock.
Largest 10 shareholders include Alerce Investment Management, L.P. (7.06M shares), Bain Capital Life Sciences Investors, LLC (4.89M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.55M shares), Redmile Group, LLC (3.5M shares), VR Adviser, LLC (3.22M shares), FEDERATED HERMES, INC. (3.06M shares), CITADEL ADVISORS LLC (2.41M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.87M shares), VANGUARD GROUP INC (1.57M shares), and GMT CAPITAL CORP (1.41M shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.